O

Orakl Oncology

HealthCancer Treatment📍 Ireland

Orakl Oncology is focused on utilizing artificial intelligence to predict the effectiveness of cancer drugs. The company aims to enhance treatment outcomes for cancer patients by leveraging advanced technology in drug development.

Total raised
Undisclosed
tracked to date
Latest round
€30 million
Nov 12, 2026

Is this your company?

Claim this profile to get matched with investors who fund Health startups in Ireland.

Claim this profile →

Funding history

  1. 1
    €30 millionNov 12, 2026
    Announcement ↗

Orakl Oncology in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile